SMYD1 and G6PD modulation are critical events for miR-206-mediated differentiation of rhabdomyosarcoma-Reference-Cited by-同舟云学术

SMYD1 and G6PD modulation are critical events for miR-206-mediated differentiation of rhabdomyosarcoma

Published:2015-04-30 Issue:9 Volume:14 Page:1389-1402
ISSN:1538-4101
Container-title:Cell Cycle
language:en
Short-container-title:Cell Cycle

Author:

Coda Davide Martino¹²³,Lingua Marcello Francesco¹²,Morena Deborah¹²,Foglizzo Valentina¹²⁴,Bersani Francesca¹²⁵,Ala Ugo⁶,Ponzetto Carola¹²,Taulli Riccardo¹²

Affiliation:

1. Department of Oncology; University of Turin; Turin, Italy

2. CeRMS; Center for Experimental Research and Medical Studies; Turin, Italy

3. London Research Institute-Cancer Research UK; London, UK

4. Medical Research Council (MRC); National Institute for Medical Research; London, UK

5. MGH Cancer Center; Harvard Medical School; Charlestown, MA USA

6. Department of Molecular Biotechnology and Health Sciences; University of Turin; Turin, Italy

Publisher

Informa UK Limited

Subject

Cell Biology,Developmental Biology,Molecular Biology

Link

https://www.tandfonline.com/doi/pdf/10.1080/15384101.2015.1005993

Reference64 articles.

1. Rhabdomyosarcoma – working out the pathways

2. Embryonic Signaling Pathways and Rhabdomyosarcoma: Contributions to Cancer Development and Opportunities for Therapeutic Targeting

3. Mechanisms of impaired differentiation in rhabdomyosarcoma

4. MicroRNA-206: The skeletal muscle-specific myomiR

5. Muscle-specific microRNA miR-206 promotes muscle differentiation

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MicroRNAs and angiosarcoma: are there promising reports?;Frontiers in Oncology;2024-05-17

2. Smyd1: Implications for novel approaches in rhabdomyosarcoma therapy;Experimental Cell Research;2024-01

3. Metabolic Pathways in Pediatric Cancers;Handbook of Cancer and Immunology;2024

4. Exosomal Long Non-Coding Ribonucleic Acid Ribonuclease Component of Mitochondrial Ribonucleic Acid Processing Endoribonuclease Is Defined as a Potential Non-Invasive Diagnostic Biomarker for Bladder Cancer and Facilitates Tumorigenesis via the miR-206/G6PD Axis;Cancers;2023-11-06

5. Brightness and shadows of mitochondrial ROS in the brain;Neurobiology of Disease;2023-08